Company Filing History:
1 out of 7 
1 out of 26 Years Active: 1997-2000
Title: Nancy Kirshbaum: Innovator in Platelet-Endothelial Cell Adhesion Molecule Research
Introduction
Nancy Kirshbaum is a prominent inventor based in Milwaukee, WI (US). She has made significant contributions to the field of biomedical research, particularly in the study of platelet-endothelial cell adhesion molecules. With a total of 2 patents to her name, her work has implications for therapeutic applications in medicine.
Latest Patents
Kirshbaum's latest patents focus on the therapeutic use of platelet-endothelial cell adhesion molecule-1. These patents detail novel, substantially isolated isoforms of human platelet-endothelial cell adhesion molecule-1, along with DNAs coding for transcripts that encode these novel isoforms. The patents also describe methods for using such DNAs to produce isoforms by expressing the DNAs, as well as promoter segments that control the transcription of human platelet-endothelial cell adhesion molecule-1 genes. The novel isoforms differ from the complete human platelet-endothelial cell adhesion molecule-1 in that they lack one or more segments near the C-terminus, which are encoded by exons 10-15 of the genes for the full-length molecules. These isoforms arise in vivo from alternative splicing of the transcript from the genes.
Career Highlights
Throughout her career, Nancy Kirshbaum has worked with notable organizations such as the Blood Center of Southeastern Wisconsin and the BloodCenter Research Foundation. Her research has been pivotal in advancing the understanding of platelet-endothelial interactions and their implications in various medical conditions.
Collaborations
Some of her notable coworkers include Peter J. Newman and Richard J. Gumina. Their collaborative efforts have contributed to the advancement of research in the field of platelet biology.
Conclusion
Nancy Kirshbaum's innovative work in the field of platelet-endothelial cell adhesion molecules has led to significant advancements in biomedical research. Her contributions continue to influence therapeutic strategies in medicine.